Unreliable respondents are the scourge of consumer panels. Our data shows that cheaters and bots typically represent the majority of commercially available diabetes patient sample. We routinely see them in healthcare provider sample as well.
When it comes to patient-reported outcome measures, getting better or worse is really the bottom line for a disease that sadly tends to get worse over time.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.
